Topic:

Chutes and Ladders

Latest Headlines

Latest Headlines

Former Pfizer general counsel Schulman joins Alnylam's board

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry.

Takeda COO Weber's reset plans include acquisitions, market expansion

Takeda's board swept aside concerns over having the company run by a non-Japanese executive, setting up Frenchman Christophe Weber to carry out the plans he believes are needed to turn around the faltering drugmaker.

Former Avila CEO Bosley signs on to lead MA's Editas

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry.

Teva chairman Frost will leave by the end of the year

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Report: Biotech backer Burrill ousted amid fraud allegations

The founder and CEO of biotech venture outfit Burrill & Co. has been booted from the firm over charges that he mismanaged investments and made unauthorized payments, according to  Forbes.

Controversial Teva chairman bows out as board revamp continues

In January, Teva chairman Dr. Phillip Frost promised some changes to the company's board in response to investor pressure. But it wasn't until Wednesday that he announced his own exit would be among them.

CEO John Johnson jumps ship as Dendreon sinks lower

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

UPDATED: Shaky Dendreon loses its CEO as debt payments loom

Looks like CEO John Johnson won't be around to go down with Dendreon if the ship sinks. Johnson resigned from the board last week and will give up his CEO post in mid-August, the company said Monday.

Merck exec joins Novartis to helm oncology unit

Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter)...

Bayer drafts Otsuka exec to lead pharma biz to big growth

Bayer's pharma division has a new president with a big task ahead of him. A week after the company announced its current leader, Andreas Fibig, would jump ship, Bayer says it's chosen an Otsuka Pharmaceutical executive to take the post.